Ticker Symbol: GLMD
Galmed Pharmaceuticals Ltd
$2.83 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Israel
Currency:
USD
Asset
Type: Common Stock
CIK:0001595353
Company Profile
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Its lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.It is also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide and plan to initiate a first in human study by the first quarter of 2021.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: galmedpharma.com
CEO: Allen Baharaff
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.45
Change:
-$0.10
(
-18.74%)
Days Range: $0.44 - $0.53
Beta: 1.14
52wk. High: $212.63
52wk. Low: $0.36
Ytd. Change -118.24%
50 Day Moving Average: $0.58
200 Day Moving Average: $14.90
Shares Outstanding: 1680232
Valuation
Market Cap: 76.1M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A